# Mayo Clinic PET Radiochemistry Facility, Rochester, MN – FDA Inspections

Source: https://www.keypedia.com/companies/mayo-clinic-pet-radiochemistry-facility/6b2304d3-2e0e-4a40-9b2d-5a95a9a873cf

> Inspection records and compliance data for Mayo Clinic PET Radiochemistry Facility in Rochester, Minnesota. 5 FDA inspections on record, 1 Form 483, last inspected September 24, 2025.

---

## Details

- Name: Mayo Clinic PET Radiochemistry Facility
- FEI Number: 3009119769
- Business Operations: POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION
- Address Line 1: 200 1st St Sw
- City: Rochester
- State: Minnesota
- Zip Code: 55905
- Country Name: United States
- Address: 200 1st St Sw, Rochester, Minnesota 55905, United States
- Country: United States

## Related Documents

- [483 - Mayo Clinic PET Radiochemistry Facility - 2025-09-24](https://www.keypedia.com/records/483/mayo-clinic-pet-radiochemistry-facility/d79fe46b-fb84-455f-ad32-1c2c96fea706) — source: FDA, date: September 24, 2025
- [FDA Inspection 1283146 - Mayo Clinic PET Radiochemistry Facility - 2025-09-24](https://www.keypedia.com/records/fda_inspections/mayo-clinic-pet-radiochemistry-facility/c91c66f9-8ab5-4221-a1ea-da5c7e4d5377) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2025
- FDA Inspection 950152 - Mayo Clinic PET Radiochemistry Facility - 2015-12-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2015
- FDA Inspection 937220 - Mayo Clinic PET Radiochemistry Facility - 2015-08-03 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 3, 2015
- [FDA Inspection 886802 - Mayo Clinic PET Radiochemistry Facility - 2014-07-11](https://www.keypedia.com/records/fda_inspections/mayo-clinic-pet-radiochemistry-facility/f590a385-688d-48ba-9990-8cfdd7506c7a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 11, 2014
- FDA Inspection 771806 - Mayo Clinic PET Radiochemistry Facility - 2012-03-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2012

## Related Companies

- [Zep Inc](https://www.keypedia.com/companies/zep-inc/e2bf15a9-eb41-4970-8e7a-5e4be5f0ec72)
- [K Patel Phyto Extractions Private Ltd](https://www.keypedia.com/companies/k-patel-phyto-extractions-private-ltd/bbf009f3-31f6-4e6e-a120-33a1b50293cf)
- [Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.](https://www.keypedia.com/companies/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/0e692896-3bde-46a7-95ed-e65be70624d2)
- [Yabao Pharmaceutical Co., Ltd. Beijing](https://www.keypedia.com/companies/yabao-pharmaceutical-co-ltd-beijing/0abb3f06-8186-4497-83ba-1cd93ffce2a6)
- [Biologische Heilmittel Heel Gmbh](https://www.keypedia.com/companies/biologische-heilmittel-heel-gmbh/e163fb49-bc67-47e3-9482-f204f12aeb64)
- [Kingkey MBC Life Technology Group Co., Ltd.](https://www.keypedia.com/companies/kingkey-mbc-life-technology-group-co-ltd/40cceb6c-350d-44d3-aeb4-9652b4e5c303)
- [CSL Plasma Inc.](https://www.keypedia.com/companies/csl-plasma-inc/5ba3e302-9206-4ced-97c5-64c8f2297c0b)
- [Vils Pharma Coating, LLC](https://www.keypedia.com/companies/vils-pharma-coating-llc/fafd512e-c895-4c48-92b7-b71a8c518d36)
- [Novo Nordisk Pharmaceutical Industries LP](https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/6bd6ea0d-568a-4f97-ba33-f6bbab29a175)
- [ABC Compounding Co., Inc.](https://www.keypedia.com/companies/abc-compounding-co-inc/ffd26af1-9fee-4ed0-acf0-9a4ac91014c2)

## Related Officers

- [Regulatory Affairs Specialist](https://www.keypedia.com/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)
